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Early detection of cancerBackground: Ultrasound and mammography alone may not always identify malignant breast lesions.
Samsung Medison has added the Smart detectTM (S-detectTM) program to its ultrasound features, and this
may improve the identification of benign and malignant breast lesions.
Objective: To evaluate the accuracy of S-detectTM, a new ultrasound added feature, and to identify benign
and malignant breast lesions in women with symptoms or signs of focal breast disease.
Methods: In a pilot study, the registered data of a selected 45 women is retrospectively audited and ana-
lyzed. These women, presenting with clinical symptoms of breast disease (diagnostic), were examined by
mammography and ultrasound. The interpretation and Hand Held Ultrasound (HHUS) have been done
with 2 radiologists determining the BIRADS classification results for every woman (benign or malig-
nant). In addition, S-detectTM was applied during the ultrasound examination, and S-detectTM findings
(benign or malignant) were recorded in either concordance or discordance with radiologists’ findings.
Biopsy was performed as a gold standard.
Results: Among the enrolled 45 women in the study, 33 (73.3%) had concordant results with the radiol-
ogists while the remaining 12 (26.6%) were discordant, in 10 (22.2%) of the 12 discordant cases, S-detectTM
findings of benign contradicted radiologists’ findings and in 2 of the cases, S-detectTM findings of malig-
nant contradicted radiologists’ findings. In the 10 discordant cases where S-detectTM recommended
benign, only 2 were correct, but in the 2 discordant cases where S-detectTM recommended malignant, both
were correct. The overall accuracy of S-detectTM was 82.22%, sensitivity 61.90%, but a specificity was 100%.
Conclusion: The use of S-detectTM in this study identified additional cases of malignancy, so this technol-
ogy may be a useful tool in addition to mammography and US for the diagnosis of breast disease. The
specificity of the S-detectTM in this study is remarkably high; yet, the sensitivity is low. Despite a small
number of cases, we suggest a larger scale study, to validate the clinical utility in using the B-mode plus
S-detectTM to enhance diagnosis in patients presenting with symptoms and signs of breast diseases.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Imaging plays an important role in the diagnostic evaluation of
breast diseases, as clinical breast examination alone has a low
probability in distinguishing benign from malignant lesions, par-
ticularly in women younger than 40 years presenting with palpa-
ble lumps or sites of pain [1,2]. A growing evidence showed that
breast ultrasound plays an integral role in breast imaging for
women in all age groups. The technical advances in the field havemade breast ultrasound an essential component of the breast
imaging evaluation [3].
On the other hand, ultrasound is an operator-dependent imag-
ing modality that requires experience to depict the breast lesion
and diagnose it with confidence. The utility of ultrasound depends
on the ability of the radiologist to characterize and classify the
detected lesion following the standardized BIRADS lexicon as a
reference [4]. Because of this limitation, ultrasound is not able to
diagnose many benign and malignant diseases of the breast by
its own [5].
Therefore, in some cases, the diagnosis is challenging when
using ultrasound alone and the contribution of S-detectTM, a Sam-
sung ultrasound feature, may add an additional tool that could
be helpful in diagnosing breast lesions.(2016),
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Ultrasound: RS80A (Samsung Medison Co., Ltd., Seoul, Korea)
with the built in new application of S-detectTM program.
Mammography: Selenia, HologicTM 2D Digital Mammography,
USA.
Work Station: SecurViewTM DX diagnostic workstation;
advanced workflow manager. High-contrast 5 Mega Pixels Liquid
Contrast Display with 8-bit graphics card and external sensor for
calibration.
3. Methods
In this pilot study, the selected 45 women had breast imaging
screening or diagnostic services. Typically, examination is done
first with digital mammography, and then followed up by an addi-
tional complementary handheld ultrasound in the same visit with
the Samsung RS80A Ultrasound machine. That device offers B-
mode plus S-detectTM, which is an artificial intelligence that uses
a data bank of test results to provide a judgment of benign, prob-
ably benign, probably malignant or malignant for the detected
lesion by ultrasound, then, compared to the standardized BIRADS
lexicon as a reference [6]. The cases evaluated by the radiologists
with BIRADS categories 2 and 3 are classified as benign cases,
while the cases evaluated with BIRADS categories 4 and 5 are
classified as malignant cases. In cases where the judgment of
benign or malignant is discordant between the radiologists and
the S-detect, an aspiration done for simple cysts, Fine Needle Aspi-
ration Cytology (FNAC) has been done for benign and probably
benign cases and core needle biopsy were used as golden standard
to support diagnostic judgment of probably malignant and malig-
nant lesions.
A dedicated breast imaging consultant radiologist with 20 years
of experience and a breast dedicated radiologist (from 2 to 5 yearsFig. 1. Participants’ flowchart showing concordance/discordance between the S-detec
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these patients without using the S-detectTM feature. After finishing
the ultrasound examination, the radiologists classified the masses
accordingly as benign or malignant using The Breast Imaging
Reporting Data System BI-RADS final assessment categories, from
BI-RADS category 2 to BI-RADS category 5 [4].
Radiologists had a consensus conference and delivered the final
assessment as to the BI-RADS category of the lesion.
After this final assessment, we applied S-detectTM to the cap-
tured US images of the lesions and obtained the results. The appli-
cation of the S-detectTM program was done twice, one in the
transverse plane and the other in the sagittal plane. The results
were recorded as normal, possibly benign or possibly malignant
(the classifications were provided by the S-detectTM program). In
cases where the results were evaluated differently in transverse
versus the sagittal views, in which they were evaluated as possibly
benign in one view and possibly malignant in the other view, the
results were classified as possibly malignant.
After the S-detectTM results were obtained, histologic diagnosis
of all lesions was made by a fine needle aspiration cytology (FNAC)
or biopsy for benign lesions or core-needle biopsy for malignant
lesions. We compared the results of radiologists’ final assessment
with the results of S-detectTM, and then compared these results with
the histologic diagnosis. The accuracy and sensitivity of the S-
detectTM in this study were calculated.
4. Results
Out of the 45 (100%) cases in this pilot study, 33 (73.3%) of the
evaluation results were concordant between the S-detectTM and the
radiologist (see Fig. 1), and of these, 22 (48.9%) were benign and 11
(24.4%) were malignant. The remaining 12 (26.7%) cases show dis-
cordance between the radiologist’s assessment and the S-detectTM
findings.t and the radiologist opinion, compared to the outcome by the aspiration/biopsy.
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and ultrasound assessment revealed a malignant lesion, but the B-
mode plus S-detectTM disagreed, suggesting a benign nature. After
biopsy being performed, in 8 (17.8%) of these cases (Box C), the
lesions were found to be indeed benign. In the remaining 2
(4.4%) of these discordant cases, the results were malignant
(Box D).
In the other 2 of these discordant cases, mammography and
ultrasound revealed a benign lesion, but the B-mode plus S-
detectTM disagreed, suggested a malignant nature. In these two
cases, S-detectTM suggested malignant lesions that have been eval-
uated as benign by the radiologists (Box A).
All cases with concordant diagnoses were confirmed by biopsy.
The sensitivity and specificity of the S-detectTM compared to the
biopsy gold standard were also calculated.
Table 1 shows the results of radiologists’ assessment, the results
of S-detectTM and final diagnosis. S-detectTM assessed the lesions in
agreement with the radiologist assessment in 33/45 cases (73.3%)
and in consensus with the biopsy results in 37/45 cases (82.2%).
The overall prevalence of confirmed breast disease in this study
is 46.67%, and the overall accuracy of S-detectTM was 82.22%. The
findings from the pilot study suggest that S-detectTM has a sensitiv-
ity of 61.90%, but a specificity of 100%.5. Example cases
There were cases in the study where the radiologists felt the
lesion was malignant and it was indeed found to be malignant,
but the S-detectTM erroneously recommended it was benign
(Box C). In these cases, the malignant nature of the lesion has been
missed by the S-detectTM.
Case 1 is an example of the 8 patients in the study where the
radiologist believed the lesion was malignant, the S-detectTM rec-
ommended it was benign, and the radiologist was ultimately foundTable 1
Comparing radiological final assessment with the S-detectTM results and correlation to Gol
Biopsy No. Radiological
Benign = 24 2 Malignant
22 Benign
Malignant = 21 19 Malignant
2 Benign
Fig. 2. A 38-year-old woman presented with a palpable lump in the right breast, 3.7 
lesion, irregular in shape. Radiologist suggested BI-RADS category 4 lesion, and the S-d
Please cite this article in press as: Gewefel HS. Can the Smart detectTM in brea
http://dx.doi.org/10.1016/j.ejrnm.2016.09.007to be correct after biopsy confirmed the lesion nature was malig-
nant (Box C).
There are also cases where both the radiologists and S-detectTM
have judged the lesion to be malignant, but upon aspiration, it has
been found to be benign. We did not report the results of biopsy/
aspirations on lesions with concordant findings in our pilot study,
but in practice, when findings were concordant for malignancy, we
performed biopsy, and in some cases, the lesion was ultimately
found to be benign.5.1. Case 1: Ultrasound and S-detect findings for a BI-RADS category
4 lesion
See Figs. 2 and 3.5.2. Case 2: Ultrasound and S-detect findings for a BI-RADS category
4 lesion
See Figs. 4 and 5.5.3. Case 3: Imaging and S-detect findings for a BI-RADS category 5
lesion (Fig. 6)
In Case 3, and similar to case 2, the US and S-detectTM findings
agreed on a malignancy, but contrary to case 2, the lesion was
found to be malignant upon biopsy.5.4. Case 4: Imaging and S-detect findings for a BI-RADS category 5
lesion (Fig. 7)
Case 4 was similar to Case 3, in that both US and S-detectTM
agreed on malignancy of the lesion, and histologic follow-up con-
firmed this diagnosis.d Standard Biopsy.
assessment No. S-detect
24 Benign
11 Malignant
8 Benign
2 Malignant
2.9 cm. Ultrasound findings show a solitary, solid, heterogeneous and hypo-echoic
etectTM suggested being possibly benign (see Fig. 3).
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Fig. 4. A 30-year-old lactating woman with a palpable lump in the left breast. Ultrasound findings of a complicated cystic lesion located at the 3 o’clock position with internal
echoes and an irregular thick margin exhibiting posterior enhancement. The radiologists judged this lesion to be malignant, and the S-detectTM also classified it as possibly
malignant. Surgical excision was performed and cytopathology proved inflammatory process underway in Case 2 (abscess formation) (see Fig. 5).
Fig. 5. The follow-up assessment of Case 2 shows the excised area by ultrasound showing a residual lesion which was evaluated as benign by the radiologist. S-detectTM
findings of Case 2 post-excision have been judged to be possibly benign.
Fig. 3. S-detectTM suggested a probably benign nature of the lesion in Case 1, while biopsy proved to be Phylloid tumor.
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2 lesion (Fig. 8)
Finally, Case 5 is an example where both the US and the
S-detectTM diagnosed the lesion as benign, and upon biopsy, this
diagnosis was confirmed.
6. Discussion
Women under 40 years of age are rarely diagnosed with breast
cancer and typically present with clinical findings. Most women
undergo mammography with/without ultrasound. Studies showed
that young women typically have radiographically dense breasts,
that can lead to misdiagnosis of malignant lesions on film mam-
mography; however, growing body of evidence has suggested that
digital mammography may have a more accurate diagnostic per-
formance in younger women. Ultrasound can add additional infor-
mation to film mammography particularly in this age group,
although it is poor in detecting carcinoma in situ (DCIS) [7].Fig. 6. A 45-year-old woman with a palpable lump in the left breast. Ultrasound shows
hyper-echogenic irregular margin (A). Color Doppler depicts marginal abnormal signa
suspicious asymmetry involving the UOQ of the left breast from 2 till 3 o’clock position (B
possibly malignant lesion (C). The biopsy provided evidence of infiltrating ductal carcin
lesion.
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phy results are interpreted as ‘‘suspicious abnormality” or ‘‘highly
suggestive of malignancy” have a high risk for breast cancer and
should undergo core-needle biopsy or needle localization for
non-palpable lesion followed by surgical biopsy, whereas symp-
tomatic women whose mammography results are interpreted as
‘‘further evaluation needed” have an average risk for breast cancer
and should undergo additional mammography views and/or ultra-
sound to decide whether the breast lesion should be biopsied.
Asymptomatic women whose mammography results are inter-
preted as ‘‘probably benign finding” have a low risk for breast can-
cer and can undergo follow-up mammography in 6 months. Both
fine-needle aspiration cytology and ultrasound are recommended
as the first diagnostic test of a palpable breast abnormality to dis-
tinguish simple cysts from solid masses. Fine-needle aspiration
cytology also helps in characterization of a solid mass. Diagnostic
mammography alone does not help in the final judgment as a clin-
ically palpable breast mass should be biopsied or should not affect
the decision to perform a biopsy [8].the findings of an inhomogeneous hypoechoic solid mass, sized 1.0  0.8 cm, with
ls of neovascularity. Mammography LCC view exhibits a corresponding indistinct
). The radiologist recommended BI-RADS category 5, and S-detectTM also suggested
oma (IDC), and in this case, the S-detectTM supported the malignant features of the
st ultrasound provide a second opinion?. Egypt J Radiol Nucl Med (2016),
Fig. 7. A 58-year-old woman with pain and palpable lump in the right breast. The US findings show an inhomogeneous hypo-echoic solid mass, size 1.8  1.2 cm, with an
hyper-echogenic margin (A). Color Doppler depicted marginal abnormal signals of neovascularity. RCC view exhibits a corresponding speculated indistinct suspicious mass
involving the UOQ of the right breast from 10 till 12 o’clock position; with pleomorphic suspicious calcific foci (B). The Radiologist suggested BI-RADS category 5 and this
agreed with S-detectTM, which suggested possibly malignancy (C). Biopsy demonstrated an invasive ductal carcinoma, so both US and S-detectTM accurately diagnosed the
lesion.
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for malignant lesions detection with a specificity of 100% com-
pared to B-mode ultrasound alone in a larger patient population
study which has a specificity of 89.2% [9]. The sensitivity of S-
detectTM in this study is 61.9% which is notably low in comparison
with B-mode ultrasound which has a sensitivity of 95.7% [9]. S-
detectTM helped to identify 2 additional cases of malignancy that
would have otherwise gone undetected by Ultrasound per se. On
the other hand, B-mode plus S-detectTM disagreed with US findings
B-mode alone in these patients and a tissue diagnosis was
prompted using core needle biopsy that identified these cases as
malignant. B-mode plus S-detectTM was less likely to be concordant
when identifying patients as having a benign or probably benign
lesion.
None of the cases in the S-detectTM erroneously classify a
malignant lesion as benign. However, in 8 cases, S-detectTM erro-
neously classified the lesion as benign, and on FNAC, it was found
to be malignant (false-negative), followed by surgical excision.Please cite this article in press as: Gewefel HS. Can the Smart detectTM in brea
http://dx.doi.org/10.1016/j.ejrnm.2016.09.007This discordance is due to the S-detectTM program that analyzes
and evaluates the lesion based on the BI-RADS US lexicon alone.
While the radiologists combine their US findings with the mam-
mography BI-RADS lexicon, and also consider clinical findings,
the S-detectTM only uses computerized analytics to develop its rec-
ommendation. One of the false-negative cases was a newly-
developed mass identified on a screening mammography visit.
The S-detectTM program is not designed to combine more parame-
ters such as the mammography features of the lesions to consider
whenmaking its diagnosis, which is likely why there were so many
false-positive cases in this study.
These false-positive cases highlight the important role played
by the patient history and the clinical findings in the diagnosis of
the lesion. One of the false-positive cases had post-operative scar-
ring that showed architectural distortion with dystrophic calcifica-
tion. The lesion found in this case was evaluated as malignant by
the B-mode plus S-detectTM; however, due to the known patient
history to the examining radiologist, this patient was assessed byst ultrasound provide a second opinion?. Egypt J Radiol Nucl Med (2016),
Fig. 8. A 22-year-old woman with a palpable lump in the left breast. US findings showmultiple rounded and oval lobulated-shaped soft tissue masses were noted, the largest
being at the upper outer quadrant of the left breast (two masses) (A). The radiologist suggested BI-RADS category 3, a benign category, and S-detectTM suggested possibly
benign (B). Biopsy confirmed the diagnosis of benign lesion by revealing the lesion to be a fibroadenoma.
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positive case came to the clinic complaining of a painful mass in
her breast and a history of fever. A complicated cystic lesion was
noted in her ultrasound examination, with internal echoes and
irregular thick margin and exhibits posterior enhancement. When
considering the patient history and clinical examination, the radi-
ologist diagnosis suggested an abscess formation, disagreeing with
S-detectTM, and the surgical excision showed inflammatory process
and abscess formation, thus confirming the radiologist’s diagnosis.
This pilot study is not without limitations. These 45 women
represent a convenience sample of both diagnostic and screening
visits. The findings from this pilot study cannot be used to draw
final conclusions.
7. Conclusion
Our findings indicate that S-detectTM in Ultrasound might pro-
vide additional radiological information for film mammography.
Few lesions depicted/described as benign were in fact diagnosed
as malignant, thus increasing case identification. Specificity of this
added S-detectTM technology was remarkably high; yet, the sensi-
tivity was low. These results show the utility of S-detectTM as a sup-
plementary for the routine clinical care.Please cite this article in press as: Gewefel HS. Can the Smart detectTM in brea
http://dx.doi.org/10.1016/j.ejrnm.2016.09.007As small number of cases, we suggest further studies with larger
sample size to validate the clinical utility in using the B-mode plus
S-detect to enhance diagnosis in patients presenting for diagnosis
or screening for breast disease.Acknowledgment
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